+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Gosling Plague Vaccine Market - Global Forecast 2026-2032- Product Image
Gosling Plague Vaccine Market - Global Forecast 2026-2032- Product Image
Sale

Gosling Plague Vaccine Market - Global Forecast 2026-2032

  • Report

  • 192 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6282175
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Gosling Plague Vaccine: Executive Summary Scope and Context

Gosling plague vaccine development concerns preventive interventions intended to reduce disease risk in domestic geese and related waterfowl. The subject sits at the intersection of veterinary immunology, poultry production, animal health regulation, biosecurity, and conservation. This summary focuses on evidence-based strategic considerations rather than market estimates, forecasts, or commercial rankings. Because publicly available information on products specifically labeled for gosling plague is limited, conclusions should be distinguished from evidence established for broader avian infectious-disease vaccination and management programs.

Biosecurity and Evidence Standards Are Reshaping Vaccine Development

The landscape is being transformed by stronger emphasis on pathogen identification, controlled vaccination protocols, flock-level surveillance, and prevention of transmission between domestic and wild birds. Regulatory expectations increasingly favor documented safety, reproducible manufacturing, validated diagnostic assays, and clearly defined target populations. Practical adoption also depends on cold-chain reliability, trained handlers, recordkeeping, and integration with sanitation, quarantine, movement controls, and wildlife-interface management. These shifts make product efficacy only one component of successful disease prevention.

Artificial Intelligence Supports Surveillance, Design, and Operational Decisions

Artificial intelligence can contribute to this field by identifying abnormal mortality patterns, prioritizing diagnostic testing, analyzing genomic and epidemiological data, and optimizing vaccination schedules under operational constraints. Computer vision and sensor-based monitoring may help detect changes in flock behavior, feed intake, or mobility earlier than manual observation alone. However, AI outputs require representative datasets, veterinary validation, transparent performance testing, and safeguards against false alarms. It should augment-not replace-laboratory confirmation, clinical judgment, regulatory review, and on-farm biosecurity decisions.

Regional Priorities Differ Across North America, Latin America, Europe, Middle East, Africa, and Asia-Pacific

North America generally emphasizes regulated veterinary biologics, laboratory surveillance, and coordinated poultry biosecurity. Latin America must balance commercial production needs with variable infrastructure, cross-border movement, and access to veterinary services. Europe places strong weight on animal-health regulation, traceability, welfare, and wildlife disease monitoring. The Middle East faces challenges linked to arid environments, logistics, migratory bird pathways, and uneven cold-chain capacity. Africa requires adaptable delivery models, affordable diagnostics, and stronger field surveillance. Asia-Pacific combines intensive poultry systems, dense wildlife interfaces, diverse regulatory regimes, and substantial need for scalable prevention and outbreak response.

ASEAN, BRICS, European Union, G7, GCC, and NATO Require Coordinated but Distinct Approaches

ASEAN cooperation is relevant to transboundary surveillance, poultry movement, and laboratory capacity across diverse production systems. BRICS members can support research collaboration, manufacturing capability, and harmonized approaches while accounting for varied regulatory environments. The European Union provides a framework for coordinated animal-health controls, traceability, and scientific assessment. G7 priorities are particularly relevant to advanced diagnostics, antimicrobial stewardship, data systems, and preparedness. GCC countries may prioritize import controls, climate-resilient logistics, and protection of concentrated poultry operations. NATO is not an animal-health regulator, but its members may intersect on biosecurity preparedness, critical infrastructure resilience, and emergency coordination.

Country Context: Regulation, Production Systems, and Surveillance Capacity Shape Priorities

Australia’s geographic isolation supports stringent import and biosecurity controls, while Brazil’s large poultry sector increases the importance of surveillance and movement management. Canada and the United States emphasize veterinary regulation, laboratory networks, and commercial flock protection. China and India require scalable programs suited to large and diverse poultry populations. Japan and South Korea place strong emphasis on rapid detection, controlled movement, and intensive production biosecurity. France, Germany, Italy, and Spain operate within European animal-health frameworks and prioritize traceability and coordinated response. The United Kingdom maintains robust disease-control and import oversight systems. Mexico faces cross-border and regional coordination needs. Russia’s priorities include domestic veterinary capacity, extensive geography, and supply-chain resilience.

Industry Leaders Should Link Product Validation to Whole-System Disease Prevention

Leaders should first define the target pathogen, susceptible species, disease endpoint, and intended use conditions before advancing a vaccine program. They should generate controlled safety and efficacy evidence, confirm diagnostic compatibility, and establish quality systems that support batch consistency. Deployment plans should pair vaccination with quarantine, sanitation, wildlife-interface controls, movement documentation, and post-vaccination surveillance. Partnerships with veterinary authorities, diagnostic laboratories, producers, and conservation bodies can improve field relevance. Decision makers should also maintain contingency plans for supply disruption, adverse-event investigation, cold-chain failure, and newly emerging pathogen variants.

Research Methodology: Evidence Review Within a Narrow Veterinary-Market Scope

This executive summary uses the supplied market topic and required geographic groupings as a framing scope, then applies evidence-based interpretation from established principles of veterinary vaccination, avian disease control, biosecurity, surveillance, regulatory science, and responsible AI use. It avoids unsupported numerical claims, market estimates, forecasts, market shares, and company-specific assertions. Where topic-specific public evidence is limited, the analysis explicitly indicates uncertainty and relies on transferable disease-prevention principles rather than presenting assumptions as verified facts. Further product decisions require pathogen-specific laboratory, field, regulatory, and epidemiological evidence.

Conclusion: Reliable Outcomes Depend on Vaccine Evidence and Integrated Biosecurity

The strategic value of a gosling plague vaccine cannot be assessed separately from pathogen confirmation, flock conditions, delivery infrastructure, regulatory authorization, and complementary biosecurity measures. Regional and country differences make standardized principles useful but operational implementation necessarily local. Artificial intelligence can strengthen surveillance and planning when governed by validated data and expert oversight. The most defensible path for industry leaders is therefore a staged program combining rigorous vaccine evaluation, transparent monitoring, resilient logistics, and coordinated veterinary governance.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Gosling Plague Vaccine Market, by Vaccine Type
7.1. Introduction
7.2. Live Attenuated Vaccine
7.3. Inactivated Vaccine
7.4. Recombinant Vaccine
7.5. Vector-based Vaccine
7.6. RNA-based Vaccine
8. Gosling Plague Vaccine Market, by Administration Route
8.1. Introduction
8.2. Injection
8.3. Oral
8.4. Aerosol
9. Gosling Plague Vaccine Market, by End User
9.1. Introduction
9.2. Commercial Poultry Farms
9.3. Research Institutes
9.4. Government Veterinary Services
9.5. Backyard Farmers
10. Gosling Plague Vaccine Market, by Distribution Channel
10.1. Introduction
10.2. Online
10.3. Offline
11. Gosling Plague Vaccine Market, by Region
11.1. Introduction
11.2. Asia-Pacific
11.3. North America
11.4. Latin America
11.5. Europe
11.6. Middle East
11.7. Africa
12. Gosling Plague Vaccine Market, by Group
12.1. Introduction
12.2. ASEAN
12.3. GCC
12.4. European Union
12.5. BRICS
12.6. G7
12.7. NATO
13. Gosling Plague Vaccine Market, by Country
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. United Kingdom
13.7. Germany
13.8. France
13.9. Russia
13.10. Italy
13.11. Spain
13.12. China
13.13. India
13.14. Japan
13.15. Australia
13.16. South Korea
14. Competitive Landscape
14.1. Market Share Analysis, 2025
14.2. Market Concentration Analysis, 2025
14.2.1. Concentration Ratio (CR)
14.2.2. Herfindahl Hirschman Index (HHI)
14.3. Recent Developments & Impact Analysis, 2025
14.4. Product Portfolio Analysis, 2025
14.5. Benchmarking Analysis, 2025
15. Company Profiles
15.1. Bio Chee
15.2. Boehringer Ingelheim Animal Health
15.3. C.V. Labs
15.4. Ceva Santé Animale
15.5. China Animal Husbandry Industry Co., Ltd.
15.6. Dechra
15.7. Elanco
15.8. Fatro
15.9. Hipra
15.10. Jilin Zhengye Biological Products Co., Ltd.
15.11. Korea United Pharm. Inc.
15.12. Lohmann Animal Health
15.13. Medion Indonesia
15.14. Merial
15.15. MSD Animal Health
15.16. QYH Biotech Co., Ltd.
15.17. Ringpu (Tianjin) Bio-Pharmacy Co., Ltd.
15.18. Vaksindo Satwa Nusantara
15.19. Venkateshwara Hatcheries Group
15.20. Virbac
15.21. Zoetis Inc.
16. Key Experts
LIST OF FIGURES
FIGURE 1. Global Gosling Plague Vaccine Market, Years Considered for the Study
FIGURE 2. Global Gosling Plague Vaccine Market, Research Design
FIGURE 3. Global Gosling Plague Vaccine Market, Research Framework
FIGURE 4. Global Gosling Plague Vaccine Market, Data Triangulation
FIGURE 5. Global Gosling Plague Vaccine Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Gosling Plague Vaccine Market Size, by Vaccine Type, 2025 vs 2032 (%)
FIGURE 7. Global Gosling Plague Vaccine Market Size, by Vaccine Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Gosling Plague Vaccine Market Size, by Administration Route, 2025 vs 2032 (%)
FIGURE 9. Global Gosling Plague Vaccine Market Size, by Administration Route, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Gosling Plague Vaccine Market Size, by End User, 2025 vs 2032 (%)
FIGURE 11. Global Gosling Plague Vaccine Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Gosling Plague Vaccine Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 13. Global Gosling Plague Vaccine Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Gosling Plague Vaccine Market Size, by Region, 2025 vs 2032 (%)
FIGURE 15. Global Gosling Plague Vaccine Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Gosling Plague Vaccine Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 17. Global Gosling Plague Vaccine Market Size, by Country, 2025 vs 2032 (%)
FIGURE 18. Global Gosling Plague Vaccine Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Gosling Plague Vaccine Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Gosling Plague Vaccine Market Segmentation & Coverage
TABLE 2. Global Gosling Plague Vaccine Market Size, 2017-2032 (USD Million)
TABLE 3. Global Gosling Plague Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 4. Global Live Attenuated Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Live Attenuated Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Live Attenuated Vaccine Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Inactivated Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Inactivated Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Inactivated Vaccine Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Recombinant Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Recombinant Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Recombinant Vaccine Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Vector-based Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Vector-based Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Vector-based Vaccine Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global RNA-based Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global RNA-based Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global RNA-based Vaccine Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Gosling Plague Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 20. Global Injection Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Injection Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Injection Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Oral Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Oral Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Oral Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Aerosol Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global Aerosol Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global Aerosol Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global Gosling Plague Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 30. Global Commercial Poultry Farms Market Size, by Region, 2017-2032 (USD Million)
TABLE 31. Global Commercial Poultry Farms Market Size, by Group, 2017-2032 (USD Million)
TABLE 32. Global Commercial Poultry Farms Market Size, by Country, 2017-2032 (USD Million)
TABLE 33. Global Research Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 34. Global Research Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 35. Global Research Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 36. Global Government Veterinary Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 37. Global Government Veterinary Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 38. Global Government Veterinary Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 39. Global Backyard Farmers Market Size, by Region, 2017-2032 (USD Million)
TABLE 40. Global Backyard Farmers Market Size, by Group, 2017-2032 (USD Million)
TABLE 41. Global Backyard Farmers Market Size, by Country, 2017-2032 (USD Million)
TABLE 42. Global Gosling Plague Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 43. Global Online Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global Online Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global Online Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global Offline Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global Offline Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global Offline Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global Gosling Plague Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Asia-Pacific Gosling Plague Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 51. Asia-Pacific Gosling Plague Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 52. Asia-Pacific Gosling Plague Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 53. Asia-Pacific Gosling Plague Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 54. Asia-Pacific Gosling Plague Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 55. North America Gosling Plague Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 56. North America Gosling Plague Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 57. North America Gosling Plague Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 58. North America Gosling Plague Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 59. North America Gosling Plague Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 60. Latin America Gosling Plague Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 61. Latin America Gosling Plague Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 62. Latin America Gosling Plague Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 63. Latin America Gosling Plague Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 64. Latin America Gosling Plague Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 65. Europe Gosling Plague Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 66. Europe Gosling Plague Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 67. Europe Gosling Plague Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 68. Europe Gosling Plague Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 69. Europe Gosling Plague Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 70. Middle East Gosling Plague Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 71. Middle East Gosling Plague Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 72. Middle East Gosling Plague Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 73. Middle East Gosling Plague Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 74. Middle East Gosling Plague Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 75. Africa Gosling Plague Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 76. Africa Gosling Plague Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 77. Africa Gosling Plague Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 78. Africa Gosling Plague Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 79. Africa Gosling Plague Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 80. Global Gosling Plague Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 81. ASEAN Gosling Plague Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 82. ASEAN Gosling Plague Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 83. ASEAN Gosling Plague Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 84. ASEAN Gosling Plague Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 85. ASEAN Gosling Plague Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 86. GCC Gosling Plague Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 87. GCC Gosling Plague Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 88. GCC Gosling Plague Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 89. GCC Gosling Plague Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 90. GCC Gosling Plague Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 91. European Union Gosling Plague Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 92. European Union Gosling Plague Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 93. European Union Gosling Plague Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 94. European Union Gosling Plague Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 95. European Union Gosling Plague Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 96. BRICS Gosling Plague Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 97. BRICS Gosling Plague Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 98. BRICS Gosling Plague Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 99. BRICS Gosling Plague Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 100. BRICS Gosling Plague Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 101. G7 Gosling Plague Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 102. G7 Gosling Plague Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 103. G7 Gosling Plague Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 104. G7 Gosling Plague Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 105. G7 Gosling Plague Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 106. NATO Gosling Plague Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 107. NATO Gosling Plague Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 108. NATO Gosling Plague Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 109. NATO Gosling Plague Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 110. NATO Gosling Plague Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 111. Global Gosling Plague Vaccine Market Size, by Country, 2017-2032 (USD Million)
TABLE 112. United States Gosling Plague Vaccine Market Size, 2017-2032 (USD Million)
TABLE 113. United States Gosling Plague Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 114. United States Gosling Plague Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 115. United States Gosling Plague Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 116. United States Gosling Plague Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 117. Canada Gosling Plague Vaccine Market Size, 2017-2032 (USD Million)
TABLE 118. Canada Gosling Plague Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 119. Canada Gosling Plague Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 120. Canada Gosling Plague Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 121. Canada Gosling Plague Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 122. Mexico Gosling Plague Vaccine Market Size, 2017-2032 (USD Million)
TABLE 123. Mexico Gosling Plague Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 124. Mexico Gosling Plague Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 125. Mexico Gosling Plague Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 126. Mexico Gosling Plague Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 127. Brazil Gosling Plague Vaccine Market Size, 2017-2032 (USD Million)
TABLE 128. Brazil Gosling Plague Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 129. Brazil Gosling Plague Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 130. Brazil Gosling Plague Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 131. Brazil Gosling Plague Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 132. United Kingdom Gosling Plague Vaccine Market Size, 2017-2032 (USD Million)
TABLE 133. United Kingdom Gosling Plague Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 134. United Kingdom Gosling Plague Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 135. United Kingdom Gosling Plague Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 136. United Kingdom Gosling Plague Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 137. Germany Gosling Plague Vaccine Market Size, 2017-2032 (USD Million)
TABLE 138. Germany Gosling Plague Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 139. Germany Gosling Plague Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 140. Germany Gosling Plague Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 141. Germany Gosling Plague Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 142. France Gosling Plague Vaccine Market Size, 2017-2032 (USD Million)
TABLE 143. France Gosling Plague Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 144. France Gosling Plague Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 145. France Gosling Plague Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 146. France Gosling Plague Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 147. Russia Gosling Plague Vaccine Market Size, 2017-2032 (USD Million)
TABLE 148. Russia Gosling Plague Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 149. Russia Gosling Plague Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 150. Russia Gosling Plague Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 151. Russia Gosling Plague Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 152. Italy Gosling Plague Vaccine Market Size, 2017-2032 (USD Million)
TABLE 153. Italy Gosling Plague Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 154. Italy Gosling Plague Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 155. Italy Gosling Plague Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 156. Italy Gosling Plague Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 157. Spain Gosling Plague Vaccine Market Size, 2017-2032 (USD Million)
TABLE 158. Spain Gosling Plague Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 159. Spain Gosling Plague Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 160. Spain Gosling Plague Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 161. Spain Gosling Plague Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 162. China Gosling Plague Vaccine Market Size, 2017-2032 (USD Million)
TABLE 163. China Gosling Plague Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 164. China Gosling Plague Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 165. China Gosling Plague Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 166. China Gosling Plague Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 167. India Gosling Plague Vaccine Market Size, 2017-2032 (USD Million)
TABLE 168. India Gosling Plague Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 169. India Gosling Plague Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 170. India Gosling Plague Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 171. India Gosling Plague Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 172. Japan Gosling Plague Vaccine Market Size, 2017-2032 (USD Million)
TABLE 173. Japan Gosling Plague Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 174. Japan Gosling Plague Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 175. Japan Gosling Plague Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 176. Japan Gosling Plague Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 177. Australia Gosling Plague Vaccine Market Size, 2017-2032 (USD Million)
TABLE 178. Australia Gosling Plague Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 179. Australia Gosling Plague Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 180. Australia Gosling Plague Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 181. Australia Gosling Plague Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 182. South Korea Gosling Plague Vaccine Market Size, 2017-2032 (USD Million)
TABLE 183. South Korea Gosling Plague Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 184. South Korea Gosling Plague Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 185. South Korea Gosling Plague Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 186. South Korea Gosling Plague Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 187. Global Gosling Plague Vaccine Market Share, by Key Player, 2025
TABLE 188. Global Gosling Plague Vaccine Market, Key Experts

Companies Mentioned

  • Bio Chee
  • Boehringer Ingelheim Animal Health
  • C.V. Labs
  • Ceva Santé Animale
  • China Animal Husbandry Industry Co., Ltd.
  • Dechra
  • Elanco
  • Fatro
  • Hipra
  • Jilin Zhengye Biological Products Co., Ltd.
  • Korea United Pharm. Inc.
  • Lohmann Animal Health
  • Medion Indonesia
  • Merial
  • MSD Animal Health
  • QYH Biotech Co., Ltd.
  • Ringpu (Tianjin) Bio-Pharmacy Co., Ltd.
  • Vaksindo Satwa Nusantara
  • Venkateshwara Hatcheries Group
  • Virbac
  • Zoetis Inc.

Related Topics

Related Reports

Inactivated Vaccines Market Report 2026 - Product Image

Inactivated Vaccines Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Coccidiosis Vaccines Market - Global Forecast 2026-2032 - Product Image

Coccidiosis Vaccines Market - Global Forecast 2026-2032

  • Report
  • 193 Pages
  • Global
From
Coccidiosis Vaccines in Chickens Market - Global Forecast 2026-2032 - Product Image

Coccidiosis Vaccines in Chickens Market - Global Forecast 2026-2032

  • Report
  • 180 Pages
  • Global
From
Avian Influenza Vaccines Market - Global Forecast 2026-2032 - Product Image

Avian Influenza Vaccines Market - Global Forecast 2026-2032

  • Report
  • 194 Pages
  • Global
From
Clostridium Vaccine Market - Global Forecast 2026-2032 - Product Image

Clostridium Vaccine Market - Global Forecast 2026-2032

  • Report
  • 196 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.